IL1B and Parkinson disease: A study conducted by Mogi et al. (1996) reported elevated levels of inflammatory cytokines, including tumor necrosis factor-alpha (TNF-α), interleukin-1 beta (IL-1β), and interleukin-6 (IL-6), in both the brain tissue and cerebrospinal fluid of patients with PD.